Stay updated on LAG-3 in GBM: Alone & with Nivolumab Clinical Trial
Sign up to get notified when there's something new on the LAG-3 in GBM: Alone & with Nivolumab Clinical Trial page.

Latest updates to the LAG-3 in GBM: Alone & with Nivolumab Clinical Trial page
- CheckyesterdayChange DetectedThe page displays the clinical-trial record, including its study design, eligibility criteria, locations, outcome measures, record history, and related publication.SummaryDifference75%

- Check8 days agoChange DetectedThe footer’s site revision label changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check15 days agoChange DetectedA site-wide banner announces NIH website transition updates and states that federal agencies are adopting “Super Intelligence” in place of “Artificial Intelligence.”SummaryDifference1%

- Check22 days agoChange DetectedThe site footer revision number changes from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check29 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check43 days agoChange DetectedThe study details page now displays a 403 Forbidden error, making the page content inaccessible and preventing retrieval of the trial information.SummaryDifference0.5%

Stay in the know with updates to LAG-3 in GBM: Alone & with Nivolumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LAG-3 in GBM: Alone & with Nivolumab Clinical Trial page.